New Article. VolitionRx is stacking catalysts heading into Q4 2026 — finger-prick sepsis detection, French reimbursement, a $5M vet milestone, and licensing talks with 10 major diagnostics players. Revenue up 40%. Not financial advice. DYOR.
https://allcapresearch.com/f/volitionrx-vnrx-...to-q4-2026
$EXAS
$ILMN
$PACB
$NTRA